Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07537751
NA

Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic Dermatitis

Sponsor: Noura Abdelmoneim Mohammed Elseessy

View on ClinicalTrials.gov

Summary

This randomized, double-blind trial compared topical crisaborole 2% with topical fluticasone propionate 0.05% in children aged 1-12 years with mild to moderate atopic dermatitis. Forty patients were assigned to receive either crisaborole or fluticasone twice daily on affected areas for 6 weeks, with responders (\>75% improvement in SCORAD) continuing the same treatment twice weekly for 12 weeks as maintenance. The study evaluated improvement in disease severity using SCORAD and ISGA, pruritus scores, disease-free survival, and local tolerability. Both treatments were effective and well tolerated; fluticasone produced faster short-term improvement, while crisaborole showed a trend toward fewer relapses and similar overall safety in this pediatric population.

Official title: Comparative Study Between Topical Crisaborole 2% and Topical Fluticasone Propionate 0.05% in Treatment of Patients With Mild to Moderate Atopic Dermatitis

Key Details

Gender

All

Age Range

1 Year - 12 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2024-02-01

Completion Date

2025-03-01

Last Updated

2026-04-17

Healthy Volunteers

No

Interventions

DRUG

Crisaborole 2% topical ointment

Crisaborole 2% topical ointment applied in a thin layer to all affected atopic dermatitis lesions twice daily for 6 weeks, followed by twice-weekly application for 12 weeks as maintenance in patients who achieve more than 75% improvement in SCORAD at Week 6.

DRUG

Fluticasone propionate 0.05% topical cream

Fluticasone propionate 0.05% topical cream applied in a thin layer to all affected atopic dermatitis lesions twice daily for 6 weeks, followed by twice-weekly application for 12 weeks as maintenance in patients who achieve more than 75% improvement in SCORAD at Week 6.

Locations (1)

Faculty of Medicine, Kafr Elsheikh University

Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt